Cargando…
Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale
OBJECTIVE: Avoidance of colorectal cancer (CRC) screening is well documented with emotional barriers deterring screening intention and uptake. However, the assessment of such aversion is limited by the available instruments focusing on siloed emotions or screening procedures, limiting relevance to t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788280/ https://www.ncbi.nlm.nih.gov/pubmed/35851704 http://dx.doi.org/10.1111/ecc.13661 |
_version_ | 1784858715943337984 |
---|---|
author | Davis, Melanie Oaten, Megan Tapp, Caley Occhipinti, Stefano |
author_facet | Davis, Melanie Oaten, Megan Tapp, Caley Occhipinti, Stefano |
author_sort | Davis, Melanie |
collection | PubMed |
description | OBJECTIVE: Avoidance of colorectal cancer (CRC) screening is well documented with emotional barriers deterring screening intention and uptake. However, the assessment of such aversion is limited by the available instruments focusing on siloed emotions or screening procedures, limiting relevance to the complete process of decision‐making in the CRC context. METHODS: To address this gap, psychometric properties of the newly developed Aversion to Bowel Cancer Screening Scale (ABCSS) were assessed using data from 640 CRC screening eligible asymptomatic community members. Item review and piloting reduced 179 items to the initial 29‐item scale. Using a holdout sample technique, exploratory and confirmatory factor analysis, reliability and validity checks were conducted. RESULTS: A three‐factor model (Fecal Occult Blood Test [FOBT] Aversion, Colonoscopy Aversion and Health Conscientiousness) with 21 items was identified. Analyses of the 21‐item ABCSS indicated excellent reliabilities for the scale and subscales (α = .91 to .95). Correlations with relevant existing measures, intention and behaviour indicated good construct validity. CONCLUSION: The ABCSS is a valid measure of aversion to CRC screening for asymptomatic community members facing the decision to undertake CRC screening. This instrument may provide a more comprehensive understanding of the decision‐making process for CRC screening. |
format | Online Article Text |
id | pubmed-9788280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97882802022-12-28 Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale Davis, Melanie Oaten, Megan Tapp, Caley Occhipinti, Stefano Eur J Cancer Care (Engl) Original Articles OBJECTIVE: Avoidance of colorectal cancer (CRC) screening is well documented with emotional barriers deterring screening intention and uptake. However, the assessment of such aversion is limited by the available instruments focusing on siloed emotions or screening procedures, limiting relevance to the complete process of decision‐making in the CRC context. METHODS: To address this gap, psychometric properties of the newly developed Aversion to Bowel Cancer Screening Scale (ABCSS) were assessed using data from 640 CRC screening eligible asymptomatic community members. Item review and piloting reduced 179 items to the initial 29‐item scale. Using a holdout sample technique, exploratory and confirmatory factor analysis, reliability and validity checks were conducted. RESULTS: A three‐factor model (Fecal Occult Blood Test [FOBT] Aversion, Colonoscopy Aversion and Health Conscientiousness) with 21 items was identified. Analyses of the 21‐item ABCSS indicated excellent reliabilities for the scale and subscales (α = .91 to .95). Correlations with relevant existing measures, intention and behaviour indicated good construct validity. CONCLUSION: The ABCSS is a valid measure of aversion to CRC screening for asymptomatic community members facing the decision to undertake CRC screening. This instrument may provide a more comprehensive understanding of the decision‐making process for CRC screening. John Wiley and Sons Inc. 2022-07-18 2022-11 /pmc/articles/PMC9788280/ /pubmed/35851704 http://dx.doi.org/10.1111/ecc.13661 Text en © 2022 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Davis, Melanie Oaten, Megan Tapp, Caley Occhipinti, Stefano Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale |
title | Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale |
title_full | Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale |
title_fullStr | Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale |
title_full_unstemmed | Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale |
title_short | Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale |
title_sort | development and psychometric evaluation of the aversion to bowel cancer screening scale |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788280/ https://www.ncbi.nlm.nih.gov/pubmed/35851704 http://dx.doi.org/10.1111/ecc.13661 |
work_keys_str_mv | AT davismelanie developmentandpsychometricevaluationoftheaversiontobowelcancerscreeningscale AT oatenmegan developmentandpsychometricevaluationoftheaversiontobowelcancerscreeningscale AT tappcaley developmentandpsychometricevaluationoftheaversiontobowelcancerscreeningscale AT occhipintistefano developmentandpsychometricevaluationoftheaversiontobowelcancerscreeningscale |